Janet Huffman - 11 Dec 2025 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: CEO and CFO
Signature: /s/ Julio C. Esquivel as Attorney-In-Fact for Janet Huffman
Issuer symbol: OGEN
Transactions as of: 11 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 15 Dec 2025, 16:55:39 UTC
Previous filing: 20 Sep 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Huffman Janet	CEO and CFO	1990 MAIN STREET, SUITE 750, SARASOTA	/s/ Julio C. Esquivel as Attorney-In-Fact for Janet Huffman	15 Dec 2025	0001866284

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	OGEN	Employee Stock Option (right to buy)	Award	$0	+250,000		$0.000000	250,000	11 Dec 2025	Common Stock	250,000	$0.9300	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.

Content

Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended. One third of the options vest on the first anniversary of the grant date and the remainder of the options subsequently vest in equal annual installments over the second and third anniversary of the grant date upon the continued performance of services by the Reporting Person to the Company through the vesting dates. The option exercise price is the Company's closing price on the date of grant.